Latest Insider Transactions at Bio Affinity Technologies, Inc. (BIAF)
This section provides a real-time view of insider transactions for Bio Affinity Technologies, Inc. (BIAF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of bioAffinity Technologies, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of bioAffinity Technologies, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 05
2024
|
James Michael Edwards VP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+46.74%
|
-
|
|
Jul 01
2024
|
Peter S Knight Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,784
+22.34%
|
-
|
|
Jul 01
2024
|
Gary D Rubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,784
+18.73%
|
-
|
|
Jul 01
2024
|
Maria Zannes President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
33,784
+12.19%
|
-
|
|
Jul 01
2024
|
Jamie Platt Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,784
+38.16%
|
-
|
|
Jul 01
2024
|
Roby Joyce Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,784
+33.65%
|
-
|
|
Jul 01
2024
|
Robert A. Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,784
+17.09%
|
-
|
|
Jul 01
2024
|
Steven Girgenti Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
33,784
+3.07%
|
-
|
|
Jul 01
2024
|
Stuart Diamond Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,784
+25.43%
|
-
|
|
Jun 12
2024
|
Gary D Rubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+6.85%
|
-
|
|
Jun 12
2024
|
Robert A. Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+5.99%
|
-
|
|
Jun 12
2024
|
Peter S Knight Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+9.02%
|
-
|
|
Jun 12
2024
|
Jamie Platt Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+28.35%
|
-
|
|
Jun 12
2024
|
Roby Joyce Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+20.17%
|
-
|
|
Jun 12
2024
|
Maria Zannes President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+3.81%
|
-
|
|
Jun 12
2024
|
Steven Girgenti Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+0.8%
|
-
|
|
Jun 12
2024
|
Stuart Diamond Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+11.27%
|
-
|
|
Apr 08
2024
|
Maria Zannes President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
28,264
-12.32%
|
$56,528
$2.65 P/Share
|
|
Apr 08
2024
|
Maria Zannes President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
64,848
+22.03%
|
$64,848
$1.16 P/Share
|
|
Apr 04
2024
|
Timothy P Zannes Secretary, EVP, Gen. Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
29,031
-38.63%
|
$58,062
$2.58 P/Share
|
|
Apr 04
2024
|
Timothy P Zannes Secretary, EVP, Gen. Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
64,848
+46.32%
|
$64,848
$1.16 P/Share
|
|
Apr 03
2024
|
Steven Girgenti Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
33,438
-3.16%
|
$66,876
$2.24 P/Share
|
|
Apr 03
2024
|
Steven Girgenti Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
64,848
+5.78%
|
$64,848
$1.16 P/Share
|
|
Feb 26
2024
|
Robert A. Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
64,848
+34.73%
|
$64,848
$1.16 P/Share
|
|
Feb 16
2024
|
Steven Girgenti Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
39,474
+3.83%
|
$39,474
$1.52 P/Share
|
|
Jan 31
2024
|
Timothy P Zannes Secretary, EVP, Gen. Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,688
+39.35%
|
-
|
|
Jan 31
2024
|
Steven Girgenti Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
11,943
+1.24%
|
-
|
|
Jan 31
2024
|
Vivienne I Rebel Chief Sci. & Med. Officer, EVP |
BUY
Grant, award, or other acquisition
|
Direct |
31,847
+40.79%
|
-
|
|
Jan 31
2024
|
Xavier Trinidad Reveles Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,720
+45.12%
|
-
|
|
Jan 31
2024
|
Maria Zannes President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
23,885
+12.67%
|
-
|
|
Jan 31
2024
|
Michael Philip Dougherty Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,847
+27.44%
|
-
|
|
Jan 01
2024
|
Jamie Platt Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,668
+50.0%
|
$12,668
$1.48 P/Share
|
|
Jan 01
2024
|
Roby Joyce Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,668
+34.05%
|
$12,668
$1.48 P/Share
|
|
Jan 01
2024
|
Robert A. Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,668
+18.18%
|
$12,668
$1.48 P/Share
|
|
Jan 01
2024
|
Stuart Diamond Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,668
+18.18%
|
$12,668
$1.48 P/Share
|
|
Jan 01
2024
|
Maria Zannes President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,668
+8.26%
|
$12,668
$1.48 P/Share
|
|
Jan 01
2024
|
Gary D Rubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,668
+10.81%
|
$12,668
$1.48 P/Share
|
|
Jan 01
2024
|
Peter S Knight Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,668
+14.39%
|
$12,668
$1.48 P/Share
|
|
Jan 01
2024
|
Steven Girgenti Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
12,668
+1.33%
|
$12,668
$1.48 P/Share
|
|
Oct 01
2023
|
Roby Joyce Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,867
+50.0%
|
$11,867
$1.58 P/Share
|
|
Oct 01
2023
|
Robert A. Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,867
+21.11%
|
$11,867
$1.58 P/Share
|
|
Oct 01
2023
|
Mohsin Y Meghji Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,867
+9.76%
|
$11,867
$1.58 P/Share
|
|
Oct 01
2023
|
Stuart Diamond Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,867
+21.11%
|
$11,867
$1.58 P/Share
|
|
Oct 01
2023
|
Maria Zannes President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,867
+8.48%
|
$11,867
$1.58 P/Share
|
|
Oct 01
2023
|
Gary D Rubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,867
+11.44%
|
$11,867
$1.58 P/Share
|
|
Oct 01
2023
|
Peter S Knight Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,867
+15.91%
|
$11,867
$1.58 P/Share
|
|
Oct 01
2023
|
Steven Girgenti Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
11,867
+1.26%
|
$11,867
$1.58 P/Share
|
|
Aug 09
2023
|
Steven Girgenti Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
26,315
+2.79%
|
$52,630
$2.28 P/Share
|
|
Jul 01
2023
|
Steven Girgenti Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
20,490
+1.14%
|
$20,490
$1.83 P/Share
|
|
Jul 01
2023
|
Peter S Knight Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,245
+16.77%
|
$10,245
$1.83 P/Share
|